Cardiff Oncology (CRDF) Insider Trading & Ownership

$3.99
-0.19 (-4.55%)
(As of 04/25/2024 ET)

Cardiff Oncology (NASDAQ:CRDF) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$41,100.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get CRDF Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cardiff Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRDF Insider Buying and Selling by Quarter

Cardiff Oncology Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/19/2023Gary W PaceDirectorBuy30,000$1.37$41,100.00  
(Data available from 1/1/2013 forward)

CRDF Insider Trading Activity - Frequently Asked Questions

Who is on Cardiff Oncology's Insider Roster?

The list of insiders at Cardiff Oncology includes Gary W Pace, James E Levine, Lale White, Mark Erlander, and Renee P Tannenbaum. Learn more on insiders at CRDF.

What percentage of Cardiff Oncology stock is owned by insiders?

6.30% of Cardiff Oncology stock is owned by insiders. Learn more on CRDF's insider holdings.

Which Cardiff Oncology insiders have been buying company stock?

The following insiders have purchased CRDF shares in the last 24 months: Gary W Pace ($41,100.00), James E Levine ($46,800.00), Lale White ($24,600.00), Mark Erlander ($14,300.00), and Renee P Tannenbaum ($17,200.00).

How much insider buying is happening at Cardiff Oncology?

Insiders have purchased a total of 95,000 CRDF shares in the last 24 months for a total of $144,000.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CRDF) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners